Search

TREVICTA 263 MG, Suspension injectable à libération prolongée

Details

--- Description
Pack Boite d'une seringue pré-remplie et deux aiguilles
Strength (Dosage) 263 MG
Laboratory MAPHAR
Ingredients Palipéridone
Therapeutic class Neuroleptique atypique
ATC code N05AX13
PPH $720.00
PPV $739.40
Refundable No
Refund base $0.00
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses Trevicta, une forme galénique injectable trimestrielle de palmitate de palipéridone, est indiqué dans le traitement de la schizophrénie chez les patients adultes traités depuis au moins quatre mois de manière appropriée avec la forme galénique injectable mensuelle de palmitate de palipéridone.
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.